Eagle Pharmaceuticals Stock (NASDAQ: EGRX) stock price, news, charts, stock research, profile.
Open | $4.600 |
Close | $4.550 |
Volume / Avg. | 283.208K / 203.834K |
Day Range | 4.510 - 4.810 |
52 Wk Range | 4.100 - 30.400 |
Market Cap | $58.960M |
P/E Ratio | 5.376 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 14.47% |
Days to Cover | 10.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Eagle Pharmaceuticals (NASDAQ: EGRX) through any online brokerage.
Other companies in Eagle Pharmaceuticals’s space includes: Kezar Life Sciences (NASDAQ:KZR), Vaxxinity (NASDAQ:VAXX), Intensity Therapeutics (NASDAQ:INTS), CARISMA Therapeutics (NASDAQ:CARM) and Immuneering (NASDAQ:IMRX).
The latest price target for Eagle Pharmaceuticals (NASDAQ: EGRX) was reported by Piper Sandler on Wednesday, August 9, 2023. The analyst firm set a price target for 17.00 expecting EGRX to rise to within 12 months (a possible 273.63% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Eagle Pharmaceuticals (NASDAQ: EGRX) is $4.55 last updated April 22, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Eagle Pharmaceuticals.
Eagle Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Eagle Pharmaceuticals.
Eagle Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.